跳至主要内容
临床试验/IRCT20201003048909N1
IRCT20201003048909N1已完成2 期

Efficacy of tranexamic acid in reducing blood loss and intra and postoperative complications in patients with placenta accrete spectrum

Ahvaz University of Medical Sciences0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Age over 18 years
  • Diagnosis of placenta accrete spectrum syndrome on ultrasound
  • Singleton pregnancy
  • Cesarean section or cesarean section hysterectomy
  • Patient consent to participate in the study

排除标准

  • History of cardiovascular diseases including coronary artery disease, myocardial infarction, severe arrhythmias, and congestive heart failure
  • history of the bleeding disorder including antiphospholipid syndrome (APS)
  • liver and kidney disease
  • known coagulation disorders
  • anemia preoperatively (hemoglobin level < 8 mg/dl)
  • history of preeclampsia or eclampsia in the current pregnancy
  • contraindication to TXA use (history of TXA allergy, venous thromboembolism, active thrombolytic diseases, acquired color vision disorders, history of seizure, pre-known hematuria, and renal failure

研究者

相似试验

Efficacy of tranexamic acid in reducing blood loss... | 临床试验